<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Platelet <z:hpo ids='HP_0000752'>hyperactivity</z:hpo> associated with <z:hpo ids='HP_0003077'>hyperlipidemia</z:hpo> may contribute to development of a prothrombotic state </plain></SENT>
<SENT sid="1" pm="."><plain>We previously showed that oxidized <z:chebi fb="2" ids="39026">low-density lipoprotein</z:chebi> (oxLDL) formed in the setting of <z:hpo ids='HP_0003077'>hyperlipidemia</z:hpo> and <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> activated platelets in a CD36-dependent manner </plain></SENT>
<SENT sid="2" pm="."><plain>We now show that <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinase c-Jun N-terminal kinase (JNK)2 and its upstream activator MKK4 were phosphorylated in platelets exposed to oxLDL </plain></SENT>
<SENT sid="3" pm="."><plain>Using apoE(-/-) mice as a model of <z:hpo ids='HP_0003077'>hyperlipidemia</z:hpo>, we showed that JNK was constitutively phosphorylated in platelets in a CD36-dependent manner </plain></SENT>
<SENT sid="4" pm="."><plain>Inhibition of src kinase activity reduced JNK phosphorylation by oxLDL </plain></SENT>
<SENT sid="5" pm="."><plain>Immunoprecipitations revealed that active phosphorylated forms of src kinases Fyn and Lyn were recruited to CD36 in platelets exposed to oxLDL </plain></SENT>
<SENT sid="6" pm="."><plain>Pharmacological inhibition of the <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinase JNK or src family kinases abolished platelet activation by oxLDL in vitro </plain></SENT>
<SENT sid="7" pm="."><plain>Using a murine carotid artery <z:mp ids='MP_0005048'>thrombosis</z:mp> model we demonstrated CD36-dependent phosphorylation of platelet JNK within <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, pharmacological inhibition of JNK prolonged <z:mp ids='MP_0005048'>thrombosis</z:mp> times in <z:mp ids='MP_0002169'>wild-type</z:mp> but not cd36-null mice in vivo </plain></SENT>
<SENT sid="9" pm="."><plain>These findings suggest that a specific CD36-dependent signaling pathway is required for platelet activation by oxLDL and may provide insights related to development of novel antiplatelet therapies more relevant to atherothrombosis than to <z:mpath ids='MPATH_458'>normal</z:mpath> hemostasis </plain></SENT>
</text></document>